A nutrigenetic tool for precision dietary management of non-alcoholic fatty liver disease deeming insulin resistance markers.

Panminerva medica(2022)

引用 2|浏览13
暂无评分
摘要
Models integrating genetic screening and insulin resistance markers can be useful for the personalization of NAFLD weight loss treatments.
更多
查看译文
关键词
Non-alcoholic fatty liver disease, Obesity, Insulin resistance
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要